Polyactiva Is A Clinical Stage Biotechnology Company Based In Melbourneaustraliafounded In 2010The Company Specializes In Ophthalmologydeveloping Biodegradable Ocular Implants Designed For Sustained Drug Deliveryits Goal Is To Enhance Treatment Outcomes For Conditions Such As Glaucoma And Post Surgical Infectionspolyactiva Has Raised A Total Of $22 73 Million In Fundingsupported By Investors Like Brandon Capital And Yuuwa Capital The Company Utilizes Its Proprietary Preziaa C Technologywhich Employs Polymeric Prodrugs For Controlledlong Term Drug Release To Targeted Ocular Tissuesthis Technology Allows For Medication Delivery Over 6Ae 12 Monthsminimizing The Need For Frequent Dosingpolyactiva S Product Pipeline Includes The Latanoprost Fa Sr Ocular Implantaimed At Treating Open Angle Glaucomaand The Levofloxacin Ocular Implantwhich Is In Early Clinical Development For Preventing Post Surgical Eye Infectionsboth Implants Are Fully Biodegradableeliminating The Need For Surgical Removal
No conferences found for this company.
| Company Name | Polyactiva Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
